Lin Yang
South China Agricultural University(CN)Nanjing University of Chinese Medicine(CN)Soochow University(TW)Soochow University(CN)Nanjing Traditional Chinese Medicine Hospital(CN)Integrated Chinese Medicine (China)(CN)Suzhou Guangji Hospital(CN)Jiangsu Provincial Academy of Traditional Chinese Medicine(CN)Panyu District Central Hospital(CN)PersonGen (China)(CN)Qilu Hospital of Shandong University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Biosimilars and Bioanalytical Methods, Immune Cell Function and Interaction, Cell death mechanisms and regulation
Most-Cited Works
- → Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt(2004)423 cited
- Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.(2018)
- → Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin(2002)370 cited
- → Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215(2004)345 cited
- Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer.(2003)
- → Activation of Phosphatidylinositol 3-Kinase/Akt Pathway by Androgen through Interaction of p85α, Androgen Receptor, and Src(2003)168 cited
- → Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells